
Coloplast A/S
CLPBY | OTC
$6.45
-$0.02 (-0.31%)
Sep 22, 2026, 11:54 AM ET · Market open
TTM Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 27.07B | 26.54B | 26.27B | 26.25B | 27.87B | 27.79B | 27.45B | 27.03B | 26.3B | 25.53B | 25B | 24.5B | 24.33B | 24.07B | 23.52B | 22.58B | 21.62B | 20.61B | 19.86B | 19.43B | 18.92B | 18.5B | 18.57B |
Cost of Revenue | 11.08B | 10.84B | 8.93B | 8.92B | 9.04B | 9.03B | 8.94B | 8.76B | 8.54B | 8.39B | 8.32B | 8.17B | 7.97B | 7.68B | 7.37B | 7.05B | 6.74B | 6.44B | 6.22B | 6.11B | 5.96B | 5.91B | 5.96B |
Gross Profit | 17.52B | 17.24B | 18.87B | 18.93B | 18.82B | 18.77B | 18.52B | 18.27B | 17.76B | 17.14B | 16.69B | 16.33B | 16.37B | 16.39B | 16.15B | 15.53B | 14.88B | 14.17B | 13.64B | 13.31B | 12.95B | 12.59B | 12.61B |
Operating Income | 7.53B | 7.42B | 7.49B | 7.55B | 7.54B | 7.57B | 7.47B | 7.38B | 7.12B | 6.97B | 6.83B | 6.77B | 6.9B | 6.93B | 6.59B | 6.44B | 6.51B | 6.36B | 6.43B | 6.36B | 5.98B | 5.75B | 5.92B |
Interest Income | 97.65M | 78.77M | 58.13M | 78.13M | 84.2M | 114.71M | 150M | 120M | 121M | 124M | 130M | 109M | 85M | 127M | 135M | 136M | 134M | 99M | 147M | 147M | 147M | 104M | 11M |
Pretax Income | 3.63B | 3.07B | 5.82B | 5.8B | 6.21B | 6.49B | 6.61B | 6.4B | 6.32B | 6.3B | 6.15B | 6.03B | 6.11B | 6.17B | 6B | 6.13B | 6.16B | 6.11B | 6.3B | 6.23B | 5.96B | 5.63B | 5.54B |
Net Income | 2.76B | 2.07B | 3.97B | 3.63B | 4.08B | 4.54B | 4.88B | 5.05B | 4.97B | 4.97B | 4.87B | 4.78B | 4.78B | 4.8B | 4.63B | 4.71B | 4.78B | 4.75B | 4.9B | 4.83B | 4.56B | 4.3B | 4.24B |
Selling & General & Admin | 10.66B | 10.47B | 10.43B | 10.41B | 10.41B | 10.38B | 10.23B | 10.07B | 9.68B | 9.25B | 8.94B | 8.63B | 8.6B | 8.55B | 8.28B | 7.8B | 7.32B | 6.82B | 6.44B | 6.25B | 6.1B | 5.94B | 5.99B |
Research & Development | 1.04B | 990.17M | 970.94M | 945.16M | 916M | 917M | 899M | 913M | 925M | 901M | 889M | 872M | 858M | 864M | 877M | 866M | 856M | 819M | 774M | 755M | 723M | 720M | 725M |
Other Expenses | -1.68B | -1.63B | 4.15M | 22.84M | -40M | -73M | -56M | -56M | -13M | -42M | -43M | -44M | -33M | -45M | -44M | -49M | -43M | -52M | -44M | -44M | -44M | -23M | -25M |
Operating Expenses | 10.02B | 9.84B | 11.41B | 11.38B | 11.28B | 11.2B | 11.05B | 10.89B | 10.58B | 10.12B | 9.79B | 9.48B | 9.42B | 9.37B | 9.11B | 8.62B | 8.13B | 7.59B | 7.17B | 6.96B | 6.78B | 6.63B | 6.69B |
Interest Expense | 680.95M | 974.62M | 1.15B | 1.19B | 1.23B | 976M | 861M | 831M | 799M | 703M | 734M | 682M | 587M | 595M | 431M | 315M | 229M | 97M | 29M | 30M | 35M | 91M | 253M |
Selling & Marketing Expenses | 4.67B | 6.91B | 6.89B | 6.9B | 9.19B | 9.2B | 9.02B | 8.83B | 8.44B | 8.05B | 7.78B | 7.52B | 7.49B | 7.43B | 7.17B | 6.8B | 6.38B | 5.96B | 5.67B | 5.49B | 5.36B | 5.18B | 5.21B |
Cost & Expenses | 19.95B | 19.53B | 19.2B | 19.12B | 20.33B | 20.23B | 19.99B | 19.66B | 19.13B | 18.52B | 18.11B | 17.66B | 17.39B | 17.05B | 16.48B | 15.67B | 14.87B | 14.03B | 13.39B | 13.07B | 12.74B | 12.55B | 12.65B |
Income Tax Expense | -8.81B | -8.69B | -7.83B | -7.5B | 2.13B | 1.95B | 1.73B | 1.34B | 1.35B | 1.33B | 1.28B | 1.24B | 1.33B | 1.37B | 1.37B | 1.42B | 1.38B | 1.36B | 1.4B | 1.41B | 1.4B | 1.33B | 1.3B |
Shares Outstanding (Basic) | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.19B | 2.18B | 2.12B | 2.12B | 2.12B | 2.12B | 2.12B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B |
Shares Outstanding (Diluted) | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.25B | 2.19B | 2.25B | 2.13B | 2.12B | 2.12B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B | 2.13B |
EPS (Basic) | 1.22 | 0.92 | 1.76 | 1.61 | 1.81 | 2.02 | 2.17 | 2.26 | 2.24 | 2.27 | 2.26 | 2.24 | 2.25 | 2.26 | 2.18 | 2.22 | 2.25 | 2.23 | 2.30 | 2.27 | 2.14 | 2.02 | 1.99 |
EPS (Diluted) | 1.22 | 0.92 | 1.76 | 1.61 | 1.81 | 2.02 | 2.17 | 2.26 | 2.23 | 2.26 | 2.24 | 2.22 | 2.25 | 2.26 | 2.17 | 2.21 | 2.25 | 2.23 | 2.30 | 2.26 | 2.14 | 2.02 | 1.99 |
EBITDA | 12.01B | 11.88B | 8.8B | 8.8B | 8.76B | 8.78B | 8.76B | 8.49B | 8.35B | 8.17B | 7.98B | 7.98B | 7.95B | 8.02B | 7.67B | 7.37B | 7.26B | 7.02B | 7.2B | 7.17B | 7.01B | 6.74B | 6.73B |
EBIT | 7.45B | 7.35B | 7.33B | 7.35B | 7.41B | 7.44B | 7.45B | 7.2B | 7.12B | 7B | 6.89B | 6.71B | 6.7B | 6.77B | 6.43B | 6.44B | 6.39B | 6.2B | 6.43B | 6.37B | 6.19B | 5.92B | 5.89B |
Depreciation & Amortization | 4.55B | 4.53B | 1.47B | 1.45B | 1.35B | 1.34B | 1.31B | 1.29B | 1.23B | 1.17B | 1.12B | 1.07B | 1.05B | 1.05B | 1.02B | 930M | 862M | 811M | 765M | 792M | 816M | 821M | 845M |
Add to Watchlist
Select watchlists to add or remove CLPBY